A 27-year-old woman, G1P0, at 7 weeks gestation presents to the clinic for her first prena… — USMLE Step 2 CK

A 27-year-old woman, G1P0, at 7 weeks gestation presents to the clinic for her first prenatal visit. She reports mild morning nausea and breast tenderness but otherwise feels well. She was diagnosed with primary hypothyroidism secondary to Hashimoto thyroiditis 4 years ago and has been taking levothyroxine $100 \mu\text{g}$ daily since that time. Her pre-pregnancy thyroid function tests were consistently within normal limits. Her vital signs are stable, and physical examination shows a normal-sized, non-tender thyroid gland without nodules.

Laboratory evaluation reveals the following:

Laboratory Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$5.2 \mu\text{U/mL}$	$0.1-2.5 \mu\text{U/mL}$ (1st trimester)
Total T4	$15.1 \mu\text{g/dL}$	$5.0-12.0 \mu\text{g/dL}$ (non-pregnant)

Which of the following is the most appropriate next step in the management of this patient's thyroid condition?

Increase the levothyroxine doseAnswer
B
Maintain the current levothyroxine dose
C
Decrease the levothyroxine dose
D
Switch from levothyroxine to propylthiouracil
E
Measure serum thyroid-stimulating immunoglobulins

Answer

The most appropriate next step is to increase the levothyroxine dose.

This patient has an elevated TSH for her gestational age, indicating inadequately treated hypothyroidism. In a normal pregnancy, elevated estrogen levels increase the hepatic production and decrease the clearance of thyroxine-binding globulin (TBG). This physiological change requires the thyroid gland to increase total hormone production to saturate the additional TBG and maintain normal free T4 levels. Patients with primary hypothyroidism (e.g., Hashimoto thyroiditis) lack this reserve. Consequently, their free T4 falls and their TSH rises. To ensure adequate fetal neurodevelopment—which is entirely dependent on maternal thyroid hormone during the first trimester—the exogenous levothyroxine dose must typically be increased by approximately 20% to 30% as soon as pregnancy is confirmed. The elevated total T4 seen in this laboratory profile is an expected artifact reflecting the increased TBG-bound fraction, not clinical hyperthyroidism.

Step-by-Step Solution

Interpret the thyroid-stimulating hormone (TSH) level in the context of the first trimester.

The TSH of

5.2 \mu\text{U/mL}

is significantly elevated above the strict first-trimester target range (

0.1-2.5 \mu\text{U/mL}

Pregnancy alters TSH reference ranges due to the stimulatory effect of hCG; elevated TSH indicates inadequate thyroid hormone replacement.

Analyze the elevated total T4 in the context of physiological pregnancy changes.

The total T4 is high purely due to estrogen-driven increases in thyroxine-binding globulin (TBG), which binds more T4, leaving less free T4 available.

Total T4 levels can be misleading during pregnancy; the elevated TSH confirms that physiologically active free T4 is insufficient.

Determine the therapeutic intervention required for a hypothyroid pregnant patient.

The levothyroxine dose must be increased (typically by about 30%).

Patients with pre-existing hypothyroidism lack the glandular reserve to intrinsically increase T4 production to saturate the new TBG and maintain adequate free hormone levels for fetal neurodevelopment.

Key Concept

Pregnancy induces an increase in estrogen, which stimulates hepatic production of thyroxine-binding globulin (TBG). Patients with pre-existing primary hypothyroidism cannot mount a compensatory increase in endogenous thyroid hormone to saturate this excess TBG, leading to reduced free T4 and elevated TSH. Consequently, levothyroxine doses typically must be increased by approximately 30% upon confirmation of pregnancy.

Estimated Time:1m 15s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic